Although treatment with low dose of BRQ alone did not significantly affect tumor growth, the combination between BRQ at the same dose and anti-PD-1 antibody strongly reduced tumor growth compared to either treatment alone [122]. The gene discussed is PDCD1; the disease is neoplasm.